| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 10.11× | 10.11× | 10.47× | 10.75× | 10.26× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −15.98× | −15.34× | −22.73× | −16.26× | −97.06× | ||
| 1.24× | 1.24× | 1.32× | 1.41× | 1.62× | ||
| 2.76× | 2.76× | 3.05× | 4.77× | 0.98× | ||
| 1.01× | 1.01× | 0.97× | 1.08× | 0.79× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 10.26 | 10.75 | 10.47 | 10.11 | 10.11 | |
| Working Capital Turnover | -97.06 | -16.26 | -22.73 | -15.34 | -15.98 | |
| Asset Turnover | 1.62 | 1.41 | 1.32 | 1.24 | 1.24 | |
| Cash Conversion (CFO/Net Income) | 0.98 | 4.77 | 3.05 | 2.76 | 2.76 | |
| CFO/EBITDA | 0.79 | 1.08 | 0.97 | 1.01 | 1.01 |